References
- Swerdlow SH, Jaffe ES, Stein H, et al. Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp 321–334.
- Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971;31: 1860–1861.
- Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989; 7: 1630–1636.
- Urba WJ, Longo DL. Hodgkin's disease. N Engl J Med 1992;326: 678–687.
- Munker R, Hasenclever D, Brosteanu O, et al. Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group. J Clin Oncol 1995;13:403–409.
- Roppe R. Hodgkin lymphoma. NCCN Clinical Practice Guidelines in Oncology, Version 2. 2012. Available from: nccn.org
- Hines-Thomas MR, Howard SC, Hudson MM, et al. Utility of bone marrow biopsy at diagnosis in pediatric Hodgkin lymphoma. Haematologica 2010;95:1691–1696.
- Simpson CD, Gao J, Fernandez CV, et al. Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: the Canadian perspective. Br J Haematol 2010;141:820–826.
- Howell SJ, Grey M, Chang J, et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol 2002;119: 408–411.
- Franco V, Tripodo C, Rizzo A, et al. Bone marrow biopsy in Hodgkin's lymphoma. Eur J Haematol 2004;73:149–155.
- Ponzoni M, Fumagalli L, Rossi G, et al. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol 2012;15:1273–1278.
- Moulin-Romsee G, Hindié E, Moretti JL. F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 2010;37:1095–1105.
- Hamilton R, Andrews I, McKay P, et al. Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study. Leuk Lymphoma 2014;55:1049–1052.
- Cortés-Romera M, Sabaté-Llobera A, Mercadal-Vilchez S, et al. Bone marrow evaluation in initial staging of lymphoma FDG PET/CT versus bone marrow biopsy. Clin Nucl Med 2014;39: e46–e52.
- El-Galaly, d’Amore F, Mylan KJ, et al. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naïve patients with Hodgkin lymphoma. J Clin Oncol 2012;30:4508–4514.
- Te Velde J, Ottolander GJ, Spaander PJ, et al. The bone marrow in Hodgkin's disease: the non-involved marrow. Histopathology 1978;2:31–46.
- Salaun PY, Gastinne T, Bodet-Milin C, et al. Analysis of 18 F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation? Eur J Nucl Med Mol Imaging 2009;36:1813–1821.
- Cerci JJ, Trindade E, Buccheri V, et al. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin Lymphoma across jurisdictions. Clin Lymphoma Myeloma Leuk 2011;11:314–320.
- Cerci JJ, Pracchia LF, Soares-Junior J, et al. Positron emission tomography with 2-[18f]-fluoro-2-deoxy-d-glucose for initial staging of Hodgkin lymphoma: a single center experience in Brazil. Clinics 2009;64:491–498.
- Kremer M, Quintanilla-Martínez L, Nahrig J. Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis. Virchows Arch 2005;447:920–937.
- Proctor SJ, Taylor P, Mackie MJ, et al. A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party. Leuk Lymphoma 1992;7:17–20.
- Mahoney DH Jr, Schreuders LC, Gresik MV, et al. Role of staging bone marrow examination in children with Hodgkin disease. Med Pediatr Oncol 1998; 30:175–177.
- Arber DA, George TI. Bone marrow involvement by Hodgkin and non-Hodgkin lymphomas. Am J Surg Pathol 2005;29:1549–1557.
- El-Galaly TC, Hutchings M, Mylam KJ, et al. Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement. Leuk Lymphoma 2014;55:2349–2355.
- Hutchings M, Loft A, Hansen M, et al. Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 2006;91:482–489.